Latest:
Budget Impact Analysis of Biosimilar Natalizumab in the US
Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.
© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Authors
Drew Hillier JD
Drew Hillier is an associate with
Latest:
Legal Opinion: BPCIA Is Likely to Survive Latest ACA Challenge
Intellectual property attorneys discuss the Supreme Court oral arguments over the Affordable Care Act (ACA) and implications for the Biologics Price Competition and Innovation Act (BPCIA).
Chase Ibia, PharmD Candidate
Chase Ibia is a PharmD candidates at the Daniel K. Inouye College of Pharmacy at the University of Hawai’i at Hilo.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to Classification
Nuances in classification for insulin biosimilars can lead to frequent areas of confusion, according to 2 pharmacists.
Camlyn Masuda, PharmD, BCACP, CDCES
Camlyn Masuda, PharmD, BCACP, CDCES, is an associate specialist of pharmacy practice at the Daniel K. Inouye College of Pharmacy at the University of Hawai’i at Hilo.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to Classification
Nuances in classification for insulin biosimilars can lead to frequent areas of confusion, according to 2 pharmacists.
Ted Mathias, JD
Ted Mathias focuses on trying patent cases. In the last 2 years, he tried 2 cases to judgment and served as lead counsel in a case involving 33 patents that settled favorably on the eve of trial. Mathias has litigated patent cases and handled successful appeals to the Federal Circuit in the areas of medical devices, pharmaceuticals, mechanical devices, e-commerce and software.
Latest:
Opinion: Purple Book Patent Listings Are Only a First Step
Intellectual property attorneys from Axinn discuss the limitations of the Purple Book patent disclosure requirements and the burden these impose on biosimilar developers.
Advertisement
Advertisement